Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Spada

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Cancers|July 27, 2024
Immunotherapy in Neuroendocrine Neoplasms: A Diamond to CutEsmeralda García-Torralba, Esther Garcia-Lorenzo, Bernard Doger, et al.
The American Journal of Case Reports|August 29, 2022
Metachronous Testicular Metastases from Merkel Cell Carcinoma (MCC): A Case Report and Literature ReviewAlice Laffi, Gabriele Cozzi, Francesca Spada, et al.
Cancer Treatment Reviews|April 30, 2026
Streptozotocin revisited: Pharmacological determinants supporting new scheduling strategies in neuroendocrine tumoursNicola Fazio, Francesca Spada, Lavinia Benini, et al.
Ecancermedicalscience|November 19, 2020
The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature reviewPaola Zagami, Eleni Kandaraki, Giuseppe Renne, et al.
Frontiers in Psychology|November 17, 2022
The association between objective cognitive measures and ecological-functional outcomes in COVID-19Marcella Ottonello, Elena Fiabane, Edoardo Nicolò Aiello, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenibGiuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, et al.
Cancer Treatment Reviews|July 8, 2014
RAF signaling in neuroendocrine neoplasms: from bench to bedsideNicola Fazio, Omar Abdel-Rahman, Francesca Spada, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2019
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumorsNicola Fazio, Chiara A Cella, Marzia Del Re, et al.
Journal of Neuroendocrinology|October 28, 2022
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysisGiulia Arrivi, Francesca Spada, Samuele Frassoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 24, 2021
[<sup>177</sup>Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspectiveFrancesca Spada, Davide Campana, Giuseppe Lamberti, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Cancers|July 27, 2024
Immunotherapy in Neuroendocrine Neoplasms: A Diamond to CutEsmeralda García-Torralba, Esther Garcia-Lorenzo, Bernard Doger, et al.
The American Journal of Case Reports|August 29, 2022
Metachronous Testicular Metastases from Merkel Cell Carcinoma (MCC): A Case Report and Literature ReviewAlice Laffi, Gabriele Cozzi, Francesca Spada, et al.
Cancer Treatment Reviews|April 30, 2026
Streptozotocin revisited: Pharmacological determinants supporting new scheduling strategies in neuroendocrine tumoursNicola Fazio, Francesca Spada, Lavinia Benini, et al.
Ecancermedicalscience|November 19, 2020
The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature reviewPaola Zagami, Eleni Kandaraki, Giuseppe Renne, et al.
Frontiers in Psychology|November 17, 2022
The association between objective cognitive measures and ecological-functional outcomes in COVID-19Marcella Ottonello, Elena Fiabane, Edoardo Nicolò Aiello, et al.
Expert Review of Anticancer Therapy|November 5, 2011
Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenibGiuseppe Cabibbo, Emanuela Rolle, Massimo De Giorgio, et al.
Cancer Treatment Reviews|July 8, 2014
RAF signaling in neuroendocrine neoplasms: from bench to bedsideNicola Fazio, Omar Abdel-Rahman, Francesca Spada, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 4, 2019
Pharmacodynamics, clinical findings and approval status of current and emerging tyrosine-kinase inhibitors for pancreatic neuroendocrine tumorsNicola Fazio, Chiara A Cella, Marzia Del Re, et al.
Journal of Neuroendocrinology|October 28, 2022
Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single-center retrospective analysisGiulia Arrivi, Francesca Spada, Samuele Frassoni, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 24, 2021
[<sup>177</sup>Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspectiveFrancesca Spada, Davide Campana, Giuseppe Lamberti, et al.
Pageof 12